Specialization
Pediatric hematology
Focus of research
Immunology of inhibitor development in mild and moderate hemophilia A
Amsterdam institute for Immunology and Infectious diseases
-
The factor VIII treatment history of non-severe hemophilia A—Response from original authors Abdi et al
Kloosterman, F. R., Abdi, A., Gouw, S. C., Hart, D. P. & Fijnvandraat, K., 1 Oct 2021, In: Journal of thrombosis and haemostasis. 19, 10, p. 2642-2644 3 p.Research output: Contribution to journal › Comment/Letter to the editor › Academic
-
Treatment-related risk factors for inhibitor development in non-severe hemophilia A after 50 cumulative exposure days: A case-control study
Abdi, A., Eckhardt, C. L., van Velzen, A. S., Vuong, C., Coppens, M., Castaman, G., Hart, D. P., Hermans, C., Laros-van Gorkom, B., Leebeek, F. W. G., Mancuso, M. E., Mazzucconi, M. G., McRae, S., Oldenburg, J., Male, C., van der Bom, J. G., the INSIGHT Study Group, Fijnvandraat, K. & Gouw, S. C., Sept 2021, In: Journal of thrombosis and haemostasis. 19, 9, p. 2171-2181 11 p.Research output: Contribution to journal › Article › Academic › peer-review
-
Counteracting coagulation: Inhibitor development in hemophilia A
Abdi, A., 2021, 182 p.Research output: PhD Thesis › Phd-Thesis - Research and graduation internal
- All publications